Eurofins Scientific revenue and financials
€76.10Change from previous close: −0.05%Absolute change: −€0.04
In the fiscal year ended December 2025, Eurofins Scientific reported revenue of €7.3B (+4.96% year over year). Net income was €474.8M, a net margin of 6.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.96%
- 2025 vs 2024
- Net income growth
- +16.83%
- 2025 vs 2024
- Net margin
- 6.5%
- 2024: 5.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,399 | 1,319 | 1,018 | 1,136 | — |
| Depreciation and amortization | 630 | 597 | 565 | 504 | — |
| Capital expenditure | -835 | -528 | -550 | -660 | — |
| Investing cash flow | -1,076 | -847 | -681 | -856 | — |
| Financing cash flow | -102 | -1,090 | 414 | -311 | — |
| Dividends paid | -108 | -95.6 | -192 | -192 | — |
| Share repurchases | -541 | -272 | -55.8 | -15.8 | — |
| Debt issued | 1,222 | 118 | 639 | 634 | — |
| Debt repaid | -311 | -478 | -90.0 | -82.9 | — |
| Effect of exchange rates | -46.6 | 9.4 | -12.7 | -0.8 | — |
| Net change in cash | 221 | -617 | 750 | -30.9 | — |
| Free cash flow | 564 | 791 | 468 | 476 | — |